The coronavirus outbreak may shut down most of the IPO market, with volatility spiking and the Renaissance IPO Index down 4.6% this week, but not all companies are caught in the headwinds. There are several bright spots, including recent biotech IPOs, defensive names, and virus-specific plays.
For the full article, sign up for a free trial of IPO Pro.
